Abilify Maintena

Abilify Maintena

aripiprazole

Manufacturer:

Otsuka

Marketer:

Otsuka
Concise Prescribing Info
Contents
Aripiprazole
Indications/Uses
Schizophrenia.
Dosage/Direction for Use
IM inj Starting & maintenance dose: 400 mg mthly (no sooner than 26 days after the previous inj). May reduce dose to 300 mg once mthly if there are AR.
Contraindications
Hypersensitivity.
Special Precautions
Increased mortality in elderly patients w/ dementia-related psychosis; cerebrovascular AR, eg, stroke in elderly patients w/ dementia-related psychosis; neuroleptic malignant syndrome; tardive dyskinesia; metabolic changes; pathological gambling & other compulsive behaviors; orthostatic hypotension; leukopenia, neutropenia & agranulocytosis; seizures; potential for cognitive & motor impairment, body temp regulation; dysphagia, QT interval, falls, venous thromboembolism, priapism, akathisia.
Adverse Reactions
Increased wt, akathisia, inj site pain, sedation. Abdominal discomfort, constipation, diarrhoea, dry mouth, toothache, vomiting.
Drug Interactions
Increased exposure w/ strong CYP3A4 inhibitors (eg, ketoconazole) or CYP2D6 inhibitors (eg, paroxetine, fluoxetine). Decreased exposure w/ strong CYP3A4 inducers (eg, carbamazepine). May enhance effect of certain antihypertensive agents. Increased intensity of sedation & orthostatic hypotension in combination w/ benzodiazepines (eg, lorazepam).
MIMS Class
ATC Classification
N05AX12 - aripiprazole ; Belongs to the class of other antipsychotics.
Presentation/Packing
Form
Abilify Maintena inj 300 mg
Packing/Price
(pre-filled dual chamber syringe) 1's (Rp1,786,470/pre-filled syringe)
Form
Abilify Maintena inj 400 mg
Packing/Price
(pre-filled dual chamber syringe) 1's (Rp1,786,470/pre-filled syringe)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in